TGFB1 and melanoma: For NK cells, the immunosuppressive effects of TGF-β1 on E4BP4 and its target IFN-γ in natural killer NK-92 cells can be reversed via Smad3 silencing in xenograft mouse models of human hepatoma and melanoma [159].